 |
|
Cervical Cancer Trial Results
6. New Data from HPV Vaccine Trials Available
(Posted: 05/22/2007) - Results from three years of follow-up data from two clinical trials of Gardasil, a vaccine that protects against the HPV viruses known to cause 70 percent of all cases of cervical cancer, have been published in the May 10, 2007, New England Journal of Medicine.
7. Vaccine Against Cervical Cancer Virus is Effective for More than Four Years
(Posted: 04/19/2006) - An experimental vaccine that protects against two types of a virus that can cause cervical cancer remained highly effective for up to 4.5 years and caused very few adverse effects, according to the April 15, 2006, issue of the Lancet.
8. Cervical Cancer Prevention in Low-Resource Areas
(Posted: 11/22/2005) - Innovative approaches to screening and treatment for cervical cancer can increase the number of women who obtain preventive treatment, according to clinical trials conducted in the United States and South Africa. The results appear in the Nov. 2, 2005, issue of the Journal of the American Medical Association.
9. Cisplatin Plus Topotecan Gives Patients with Advanced Cervical Cancer More Time
(Posted: 08/17/2005) - Women with advanced cervical cancer who were treated with a combination of cisplatin (Platinol®) and topotecan (Hycamtin®) lived a few months longer, and went longer without their disease progressing, than patients who received cisplatin alone. The additional toxicity did not significantly affect their quality of life compared to the cisplatin-only patients, according to two reports published in the July 20, 2005, issue of the Journal of Clinical Oncology.
10. Vaccine May Help Reduce Risk of Cervical Cancer
(Posted: 05/11/2005) - An experimental vaccine prevented young women from becoming persistently infected with two types of a virus that, together, cause more than two-thirds of all cases of cervical cancer, according to the May 2005 issue of The Lancet Oncology.
< Previous 1 2 3 Next >
|
|
|
